PeterLabs Holdings Bhd
KLSE:PLABS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.108
0.245
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
PeterLabs Holdings Bhd
Cost of Revenue
PeterLabs Holdings Bhd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Cost of Revenue
-myr154.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Cost of Revenue
-myr743.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Cost of Revenue
-myr162.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Cost of Revenue
-myr203.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Cost of Revenue
-myr506.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PeterLabs Holdings Bhd
Glance View
PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.
See Also
What is PeterLabs Holdings Bhd's Cost of Revenue?
Cost of Revenue
-154.2m
MYR
Based on the financial report for Sep 30, 2024, PeterLabs Holdings Bhd's Cost of Revenue amounts to -154.2m MYR.
What is PeterLabs Holdings Bhd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%
Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for PeterLabs Holdings Bhd have been -4% over the past three years , -15% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
